Literature DB >> 12780676

Two- to three-fold increase in blood tacrolimus (FK506) levels during diarrhea in liver-transplanted children.

Juan Iglesias Berengue1, Jesús Alberto López-Espinosa, Juan Ortega-López, Luz Sánchez-Sánchez, Patricia Castilla-Valdes, Marino Asensio-Llorente, Carlos Margarit-Creixell.   

Abstract

BACKGROUND: The diagnosis and treatment of diarrhea in liver transplant recipients often pose a challenge owing to the variety of infectious and non-infectious causes. However, diagnosis is principally focused on ruling out an infectious etiology. Tacrolimus, an immunosuppressive agent generally used after liver transplantation, is absorbed mainly from the duodenum through the upper jejunum. It can be assumed that metabolism of the drug will be influenced by diarrhea.
METHODS: Four liver transplant recipients who developed an episode of acute gastroenteritis. Infectious etiology was confirmed; trough tacrolimus levels were measured before, during and after gastroenteritis.
RESULTS: All patients presented a two- to three-fold increase in blood tacrolimus levels after the onset of gastroenteritis.
CONCLUSIONS: Until the role played by the intestine in the metabolism of tacrolimus is fully understood, it is prudent to recommend early dose reduction of tacrolimus and careful monitoring of trough levels during diarrheal disorders of any nature in pediatric liver-transplanted patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12780676     DOI: 10.1034/j.1399-0012.2003.00043.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  1 in total

1.  Raised tacrolimus level and acute renal injury associated with acute gastroenteritis in a child receiving local rectal tacrolimus.

Authors:  Cheng Hiang Lee; Natalie Tasker; Erik La Hei; Shoma Dutt
Journal:  Clin J Gastroenterol       Date:  2014-04-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.